Article
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
29 Mar 2013
Abstract excerpt
Vaccine development to induce broadly neutralizing antibodies (bNAbs) against HIV-1 is a global health priority. Potent VRC01-class bNAbs against the CD4 binding site of HIV gp120 have been isolated from HIV-1-infected individuals; however, such bNAbs have not been induced by vaccination. Wild-type gp120 proteins lack detectable affinity for predicted germline precursors of VRC01-class bNAbs, making them poor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
